940 related articles for article (PubMed ID: 32872311)
1. CRISPR-Cas9 DNA Base-Editing and Prime-Editing.
Kantor A; McClements ME; MacLaren RE
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872311
[TBL] [Abstract][Full Text] [Related]
2. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
3. Advances in base editing with an emphasis on an AAV-based strategy.
Kuang J; Lyu Q; Wang J; Cui Y; Zhao J
Methods; 2021 Oct; 194():56-64. PubMed ID: 33774157
[TBL] [Abstract][Full Text] [Related]
4. Current Status and Challenges of DNA Base Editing Tools.
Jeong YK; Song B; Bae S
Mol Ther; 2020 Sep; 28(9):1938-1952. PubMed ID: 32763143
[TBL] [Abstract][Full Text] [Related]
5. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
Yu C; Mo J; Zhao X; Li G; Zhang X
Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
[TBL] [Abstract][Full Text] [Related]
6. Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors.
Sürün D; Schneider A; Mircetic J; Neumann K; Lansing F; Paszkowski-Rogacz M; Hänchen V; Lee-Kirsch MA; Buchholz F
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32384610
[TBL] [Abstract][Full Text] [Related]
7. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
[TBL] [Abstract][Full Text] [Related]
8. Off-Target Editing by CRISPR-Guided DNA Base Editors.
Park S; Beal PA
Biochemistry; 2019 Sep; 58(36):3727-3734. PubMed ID: 31433621
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
[TBL] [Abstract][Full Text] [Related]
10. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
Najah S; Saulnier C; Pernodet JL; Bury-Moné S
BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
[TBL] [Abstract][Full Text] [Related]
11. PnB Designer: a web application to design prime and base editor guide RNAs for animals and plants.
Siegner SM; Karasu ME; Schröder MS; Kontarakis Z; Corn JE
BMC Bioinformatics; 2021 Mar; 22(1):101. PubMed ID: 33653259
[TBL] [Abstract][Full Text] [Related]
12. Genome editing: An insight into disease resistance, production efficiency, and biomedical applications in livestock.
Yuan YG; Liu SZ; Farhab M; Lv MY; Zhang T; Cao SX
Funct Integr Genomics; 2024 May; 24(3):81. PubMed ID: 38709433
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications.
Molla KA; Yang Y
Trends Biotechnol; 2019 Oct; 37(10):1121-1142. PubMed ID: 30995964
[TBL] [Abstract][Full Text] [Related]
14. Engineering the Delivery System for CRISPR-Based Genome Editing.
Glass Z; Lee M; Li Y; Xu Q
Trends Biotechnol; 2018 Feb; 36(2):173-185. PubMed ID: 29305085
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide target specificity of CRISPR RNA-guided adenine base editors.
Kim D; Kim DE; Lee G; Cho SI; Kim JS
Nat Biotechnol; 2019 Apr; 37(4):430-435. PubMed ID: 30833658
[TBL] [Abstract][Full Text] [Related]
16. Targeted Nucleotide Editing Technologies for Microbial Metabolic Engineering.
Arazoe T; Kondo A; Nishida K
Biotechnol J; 2018 Sep; 13(9):e1700596. PubMed ID: 29862665
[TBL] [Abstract][Full Text] [Related]
17. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
18. In vivo somatic cell base editing and prime editing.
Newby GA; Liu DR
Mol Ther; 2021 Nov; 29(11):3107-3124. PubMed ID: 34509669
[TBL] [Abstract][Full Text] [Related]
19. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
Naeem M; Majeed S; Hoque MZ; Ahmad I
Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
[TBL] [Abstract][Full Text] [Related]
20. CRISPR DNA base editors with reduced RNA off-target and self-editing activities.
Grünewald J; Zhou R; Iyer S; Lareau CA; Garcia SP; Aryee MJ; Joung JK
Nat Biotechnol; 2019 Sep; 37(9):1041-1048. PubMed ID: 31477922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
